Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-041583

Chief Executive Officer sold 5,275 shares at $3.05 ($16,063)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-07-05 Sale : show line 1 in the form 10b5-1 −5,275 $3.05 $16,063 915,641 D
Open-market sales · 5,275 sh · avg $3.05 · $16,063
Loading xslF345X04/doc4.xml…